Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare
Author:
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00404-022-06463-x.pdf
Reference29 articles.
1. Bortlik M, Machkova N, Duricova D et al (2013) Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-alpha therapy during pregnancy: three-center study. Scand J Gastroenterol 48(8):951–958. https://doi.org/10.3109/00365521.2013.812141
2. Gotestam Skorpen C, Hoeltzenbein M, Tincani A et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795–810. https://doi.org/10.1136/annrheumdis-2015-208840
3. Mahadevan U, McConnell RA, Chambers CD (2017) Drug safety and risk of adverse outcomes for pregnant patients with inflammatory bowel disease. Gastroenterology 152(2):451-462e2. https://doi.org/10.1053/j.gastro.2016.10.013
4. Ngian GS, Briggs AM, Ackerman IN, Van Doornum S (2016) Safety of anti-rheumatic drugs for rheumatoid arthritis in pregnancy and lactation. Int J Rheum Dis 19(9):834–843. https://doi.org/10.1111/1756-185X.12860
5. Nguyen GC, Seow CH, Maxwell C et al (2016) The toronto consensus statements for the management of inflammatory bowel disease in pregnancy. Gastroenterology 150(3):734-757.e1. https://doi.org/10.1053/j.gastro.2015.12.003
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology;Reumatismo;2024-09-11
2. Safety of biologic immunosuppressants in pregnant women with immune-mediated inflammatory diseases;Journal of Autoimmunity;2024-09
3. Risk Assessment and Optimization for Pregnancy in Patients with Rheumatic Diseases;Diagnostics;2024-07-02
4. Obstetric outcomes of patients with inflammatory bowel disease;Archives of Gynecology and Obstetrics;2024-06-04
5. Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system;eClinicalMedicine;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3